FDA approves sBLA for dupilumab to treat CRSwNP in patients between the ages of 12 and 17.

Published Date: 16 May 2024

The sBLA has been approved for Priority Review designation by the federal agency, and September 15, 2024, is the target action date.

Read Full News

Latest News

US Senator Durbin Urges RFK Jr. to Resist Easing Vape Rules

U.S. Senator Dick Durbin urged Health Secretary Robert F. Kennedy Jr. on Wednesday to resist an easing of rules on ⁠flavoured vapes, saying the moves were short-sighted and...

US Health Secretary Kennedy Fires Heads Of Key Preventive Health Panel

U.S. Health Secretary Robert F. Kennedy Jr. fired the chair and vice chair of the influential task force that decides what preventive medical care should be ⁠provided at no...

Spinal Anesthesia for Circumcision Tops General Anesthesia

Spinal anesthesia offers faster recovery, similar OR time, and significantly less opioid use, with no increase in cost or OR delays.

Vegetarian Diet in Kids Not Linked to More Nutrition Risk

Though no association was seen between eating a vegetarian diet and nutrition risk, there were too few vegan children in the study to assess their nutrition risk.

Cash Transfers Cut Infant Maltreatment Reports

A universal prenatal and infant cash prescription program was associated with a decrease in investigated maltreatment allegations within the first 6 months of life.

The ITP Expert Exchange: Translating Evidence Into Evolving Practice

The ITP Expert Exchange: Translating Evidence Into Evolving Practice

Todays Updates

EMA Backs Breast Cancer SERD After FDA No Vote

The recommendation follows phase 3 data showing longer progression-free survival when patients switched to camizestrant plus a CDK4/6 inhibitor.

Datopotamab Deruxtecan Earns New Breast Cancer Indication

The antibody drug conjugate was approved by the FDA for certain patients with triple-negative breast cancer.

Todays Updates

EMA Backs Breast Cancer SERD After FDA No Vote

The recommendation follows phase 3 data showing longer progression-free survival when patients switched to camizestrant plus a CDK4/6 inhibitor.

Datopotamab Deruxtecan Earns New Breast Cancer Indication

The antibody drug conjugate was approved by the FDA for certain patients with triple-negative breast cancer.

Latest News

U.S. Senator Dick Durbin urged Health Secretary Robert F. Kennedy Jr. on Wednesday to resist an easing of rules on ⁠flavoured vapes, saying the moves were short-sighted and...

U.S. Health Secretary Robert F. Kennedy Jr. fired the chair and vice chair of the influential task force that decides what preventive medical care should be ⁠provided at no...

Spinal anesthesia offers faster recovery, similar OR time, and significantly less opioid use, with no increase in cost or OR delays.

Though no association was seen between eating a vegetarian diet and nutrition risk, there were too few vegan children in the study to assess their nutrition risk.

A universal prenatal and infant cash prescription program was associated with a decrease in investigated maltreatment allegations within the first 6 months of life.

The ITP Expert Exchange: Translating Evidence Into Evolving Practice

News All Time

RFK Jr. Faced Congress. A Physician-Senator's Competing Loyalties Were on Display.

Bill Cassidy, who is seeking reelection, walked a fine line

Vaccines, Budget Cuts, Affordability: Takeaways From RFK Jr.'s Gauntlet of Hearings

Kennedy acknowledged some HHS cuts are "painful"

Kids With Chronic Health, Social Needs More Likely to Frequently Miss School

Weighted study sample represented more than 49 million U.S. kids

South Carolina's Measles Outbreak Is Over After Sickening Nearly 1,000 People

But health officials are still on guard

FDA Analysis Says Infant Formula Supply Is Safe After Testing for Contaminants

"There's no reason not to use any available formula," said one expert

Chocolate Product Recall; Trump Admin Fights Vaccine Ruling; Measles in Travelers

Health news and commentary gathered by MedPage Today staff

New Maintenance Option Approved for Asthma

Breztri becomes the first single-inhaler triple therapy for patients as young as 12 years

Trump's New Surgeon General Pick Has Both Praised and Cringed at His Administration

Nicole Saphier is a radiologist and former Fox News Channel contributor

Telemedicine Visits Tied to Fewer Antibiotics for Respiratory Infections

Findings for virtual visits with primary care suggested high quality

Did Newborn Die From Mom's Marijuana Use?

Diagnosis of exclusion leads to answer of... probably

Teen Seeks Care for Delayed Growth Compared With His Twin

Case shows confluence of hormone therapy cost and limited resources in developing areas

This Common Household Product Tied to Kid's Seizures

Investigation revealed the likely cause of salicylate intoxication

Pediatrics Group Issues New Guidance on Recess for the First Time in 13 Years

Guidelines come after years of shrinking recesses and worsening children's health

Medicaid Expansion Tied to Lower Mortality Among Young Adults With Kidney Failure

— Cohort study focused on 1-year mortality among 19- to 23-year-olds starting dialysis

Pediatricians Prepared to Manage Mood Disorders With SSRI

Pediatricians have reported feeling less comfortable discussing emotional regulation skills, cognitive behavioral therapy, or second-line medications with families.

US FDA Says Testing Reveals Domestic Infant Formula Supply Is Safe

The U.S. Food and Drug Administration on Wednesday said tested samples of infant formula available in the country contained very low levels of ⁠contaminants, confirming that...

Recommended News For You

Multidrug Regimen Could Change Treatment Landscape for Relapsed/Refractory DLBCL

Innovative oncology therapeutics are being created in collaboration between Moderna and Immatics.

Researchers Challenge USPSTF's Lung Cancer Screening Criteria

Pancreatic Cancer: A Novel CD40 Agonist-Chemo Combo Shows Promise.

For older LBCL patients, Axi-Cel exhibits durable responses and extends overall survival.

A study on lung cancer provides additional proof of the value of screening.

Experts Debate AQUILA Trial Findings in Smoldering Multiple Myeloma

Recommended Articles For You

Harnessing Cuproptosis: A Novel Nanomedicine Strategy for Triple-Negative Breast Cancer 

Neoepitope Vaccines in Oncology: Precision, Sequencing, and Immunotherapy Frontiers 

A Comprehensive Guide to Using an ABG Calculator for Accurate Diagnosis 

Cancer-Keeper Genes: Novel Therapeutic Targets for Disrupting Tumor Maintenance 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Imfinzi + Imjudo, EU approved for patients with advanced lung cancer and non-small cell lung cancer: AstraZeneca

2.

More Support for Early Detection; Cancer in Men Rising; Diet Drives Colon Cancer

3.

Asymptomatic Brain Metastases in EGFR-Mutant NSCLC

4.

Mapping lifelong chronic health risks for childhood cancer survivors

5.

Adding Chemo to Osimertinib Doubles PFS in Advanced NSCLC

1.

Respiratory Ramifications of Systemic Disease: A Comprehensive Review

2.

Revolutionizing Lung Cancer Treatment: Exploring the Benefits of Wedge Resection Surgery

3.

Trends in Incidence, Care, and Surgery for Medullary Thyroid Cancer: A Review

4.

Cancer Care Advances: Metformin, Digital Tools, and Artificial Renal Support

5.

Molecular Mechanisms, Clinical Efficacy, and Stem Cell Therapy Integration in Leukemia Treatment

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Treatment Paradigm for Patients with R/R Adult B-cell ALL- Expert Discussions

2.

First Line Combination Therapy- The Overall Survival Data in NSCLC Patients

3.

Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC

4.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II

5.

Expert Group meeting with the management of EGFR mutation positive NSCLC - Part III

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot